ISpecimen Announces Pricing Of $5M Public Offering Of Common Stock And Pre-Funded Warrants
ISpecimen Announces Pricing Of $5M Public Offering Of Common Stock And Pre-Funded Warrants
iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of its public offering of approximately $5 million of the Company's common stock, and/or pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.0001 per pre-funded warrant). The Company intends to use the proceeds of the offering for repayment of outstanding debt, potential acquisitions of assets or investments in businesses, products and technologies and for marketing and advertising services. The remainder of proceeds will be used for working capital purposes.
iSpecimen公司(納斯達克股票代碼:ISPC)("iSpecimen"或"公司")是一家在線全球市場,連接需要醫療研究生物標本的科學家與醫療標本供應商網絡。今天宣佈以每股3.00美元的公開發行價格公開發行約500萬美元的公司普通股,和/或股價每股3.00美元的預售認股證書(每份預售認股證書減0.0001美元)。公司打算使用募集資金償還未償還債務,潛在收購資產或投資於企業、產品和技術,以及用於營銷和廣告服務。其餘款項將用於營運資金。
WestPark Capital, Inc. is acting as the exclusive placement agent in connection with the offering.
WestPark Capital, Inc.將作爲本次發行的專屬包銷商。
譯文內容由第三人軟體翻譯。